Part 9: History, Magnitude, Geographic Coverage, and

Consequences of Research Misconduct

1. Introduction

Research integrity is the foundation of public trust in the academic research system. It is the
backbone value of the scientific research and community which strongly affirmed by researchers
at all levels. It very important for professionals throughout the affiliated research infrastructure,
including funders, oversight agencies, journals, and administrative bodies(1). Compromization of
research integrity can threaten financial, political, social support for research and also the
autonomy of the academic profession(1).

When we look into the history of research misconduct, broadly defined as fabrication,
falsification, and plagiarism-has been existed as long as organized science itself. Despite
scientific inquiry is built on principles of honesty and transparency, history revealed that
repeated breaches of this value has occurred at different time and areas around the world(2).
Research misconduct is not limited to any unique discipline, era, or geography. It is a worldwide
issue with far-reaching consequences(2).

In recent decades, several high-profile cases have revealed serious misconduct among scientists.
Dutch social psychologist Diederik Stapel fabricated over 50 influential studies, often producing
results that aligned with liberal academic beliefs—such as claims that messy environments foster
racism, meat consumption promotes selfishness, and power undermines morality. His fraudulent
work elevated him to prominence until students exposed him. Similarly, Eric Poehlman, a
medical researcher at the University of Vermont, falsified data in 10 studies about metabolic
changes in menopausal women. He defrauded the government of $2.9 million in grants and
became the first U.S. scientist imprisoned for scientific fraud(3).

Empirical evidence persistently showed that the prevalent of research misconduct is high. For
example, a study conducted to assess the prevalence and patterns of research misconduct showed
that most participants knew what plagiarism was, but very few understood its different types.
Research misconduct was reported by 62.1% of faculty and 91.4% of postgraduates, with

1
plagiarism being the most common form, followed by fabrication and falsification. The main
reasons given were lack of facilities and lack of time(4).

Research misconduct damages the credibility of science, weakens public trust, and fuels
misinformation. Because journals are the main channel for publishing research, reviews, and
opinions, they play a central role in addressing misconduct. Investigations typically involve
authors, journal editors, institutional research integrity officers, and sometimes funding agencies,
all working together to evaluate and respond to suspected cases(5). Studying the research
misconduct its prevalence, geographical distribution, and its consequence has a paramount
importance to prevent its occurrence in the future generation. Therefore, the purpose of this essay
work is to examine the history, magnitude, geographical coverage, and consequences research
misconduct.

2. Rationale

Studying the history and scope of research misconduct is essential for several reasons. For one
thing, understanding past cases help identify recurring patterns and systemic weakness. It also
help us to quantify misconducts and reveal its prevalence and impact on scientific progress. It
also helps us to identify the geographical coverage of the problem. This in turn leads us to
understand the occurrence of research misconduct across continents, cultures, and disciplines and
propose international solutions for the problem. It also help us to understand the past cases of
research misconduct and set preventive mechanisms to prevent the future occurrences.

3. Method

This essay has been organized as a mini literature review using the available literatures on the
history, magnitude, geographical distribution, and consequences of research misconduct. The
primary source database used in this essay work is Google Scholar. Additional literatures were
searched manually.

2
 4. Body

4.1. History of research misconduct

The history of research misconduct shows how awareness and regulation developed over time. In
the United States and Canada, serious fraud cases in the 1980s led to the creation of formal
oversight bodies, such as the Office of Research Integrity in the U.S. Canada adopted similar
frameworks, emphasizing institutional accountability. In Europe, early responses were
fragmented, handled mainly by universities or professional societies. Denmark became a pioneer
with national committees on scientific dishonesty, which influenced other countries. The UK and
others later established more formal systems, balancing local autonomy with national oversight.
Globally, misconduct was initially documented mostly in Western countries, but by the 2000s
major scandals appeared in Asia, such as the Korean stem-cell fraud, showing that misconduct is
a worldwide issue. These events pushed for international collaboration and shared ethical
standards. Overall, the history reflects a shift from isolated scandal responses to structured
national and global systems for prevention and investigation(2).

Scientific misconduct was once handled quietly within universities and laboratories, but starting
in the 1970s and 1980s, high-profile fraud cases brought it into the public eye. Media coverage
and Congressional hearings turned misconduct into a national issue. Early debates focused on
whether fraud was rare and isolated or a systemic problem requiring federal oversight. Cases
such as William Summerlin’s fabricated experiments, John Darsee’s falsified data at Harvard,
and Stephen Breuning’s psychiatric research fraud highlighted the seriousness of the problem.
The Baltimore/Imanishi-Kari controversy further intensified scrutiny(6).

Congress criticized universities and agencies for slow investigations and coverups, pushing for
stronger oversight. The NIH eventually created policies and the Office of Research Integrity,
while the NSF integrated misconduct oversight into its Inspector General’s office. Journals
struggled with retractions, fearing lawsuits, which raised questions about peer review and the
reliability of published science(6).

The historical overview concludes that resistance and poor communication from scientific
leaders worsened relations with policymakers, leading to more regulation. Today, oversight
3
systems exist but remain imperfect. The rise of electronic publishing adds new risks like
plagiarism and data manipulation, prompting journals to adopt stricter authorship and conflict-of-
interest rules. The lesson is that proactive ethical engagement by scientists can prevent scandals
and reduce the need for heavy regulation(6).

The history of fraud and misconduct in biomedical research shows how awareness of dishonesty
in science gradually developed into formal systems of oversight. Early cases in the 1970s and
1980s, such as fabricated experiments and falsified data, revealed that misconduct was not just
rare accidents but a recurring problem. These scandals attracted media attention and
Congressional hearings in the United States, which pushed universities and federal agencies to
take action. The U.S. eventually created the Office of Research Integrity (ORI) to investigate and
manage cases, while the National Science Foundation integrated oversight into its Inspector
General’s office(7).

In Europe, responses were slower and more fragmented. Denmark pioneered national
committees on scientific dishonesty, which became a model for other countries. Britain, France,
and Germany were criticized for lacking strong systems, relying instead on ad hoc institutional
responses. By the 1990s and 2000s, more countries—including Canada, Finland, and Norway—
developed mechanisms to handle misconduct(7).

Globally, misconduct cases later emerged in Asia, such as the Korean stem-cell scandal, showing
that fraud was not confined to Western science. These events highlighted the need for
international standards and cooperation(7).

Overall, the historical record reflects a shift from isolated scandals handled quietly to structured
national and international systems. While serious fraud remains relatively rare, the history
demonstrates that prevention, transparency, and independent oversight are essential to maintain
trust in biomedical research(7).

4
 4.2. Magnitude of Research Misconduct

The magnitude of scientific misconduct is measure by the number and proportion of the retracted
papers. Different empirical studies revealed that significant numbers of research articles are
retracted due to scientific misconducts such as fabrication and falsifying data (8).

A study of Understanding the patterns and magnitude of life science publication retractions
revealed that retractions in life science publications have grown steadily reflecting both the scale
of scientific output and the persistence of misconduct and errors. In this study analysis of more
than 13,000 retraction records shows that the number of retractions has increased by 12–20%
across the decades, with a sharp rise in recent years(8). Regarding the geographic distribution of
the magnitude the study revealed that China accounts for the largest share of retractions (about
39%), followed by the United States (16%) and India (5%), with other countries such as Japan,
Germany, the UK, South Korea, and Iran also contributing significant numbers(8). Subject areas
most affected include interdisciplinary life sciences, cell biology, and cancer biology. The main
reasons for retraction are ethical and regulatory non-compliance, publication integrity issues such
as fake peer review or authorship disputes, and data integrity problems. Journals with high
retraction counts include PLOS One, Journal of Biological Chemistry, and European Review for
Medical and Pharmacological Sciences, while even top-tier journals like Nature and Science
have faced notable cases. Publishers such as Elsevier, Springer, Wiley, and IEEE are among
those with the highest retraction loads. Overall, the findings of this study highlight that
retractions are not isolated events but part of a global pattern, underscoring the need for stronger
research integrity policies, ethics training, and transparent retraction practices(8).

Another study conducted on misconduct accounts for the majority of retracted scientific
publications shows that 2,047 retracted articles indexed in PubMed up to May 2012 and found
that misconduct accounts for the majority of retractions. Specifically, 67% were due to
misconduct, with fraud or suspected fraud responsible for 43%, duplicate publication for 14%,
and plagiarism for 10%. Only about 21% of retractions were attributed to honest error. The study
also revealed that retractions due to fraud have increased nearly tenfold since 1975, showing a
sharp rise in recent decades. The study added that fraud-related retractions were concentrated in
countries with established research traditions such as the United States, Germany, Japan, and

5
China, while plagiarism and duplication were more common in countries like China and India.
High-impact journals such as Nature, Science, and PNAS were disproportionately affected by
fraud, whereas plagiarism and duplication were more frequent in lower-impact journals. Overall,
the study highlights that the magnitude of retractions, especially due to fraud has become the
dominant cause, raising serious concerns about the integrity of scientific publishing(9).

A cross-sectional study conducted in two medical colleges in Telangana, India, revealed high
levels of research misconduct among both faculty and postgraduate students. Among faculty,
62% admitted to misconduct, with plagiarism (41%) being the most common, followed by
fabrication (19%) and falsification (2%). Among postgraduates, misconduct was even higher at
91%, with plagiarism (64%) and fabrication (26%) dominating. The main reasons cited were
lack of facilities, lack of time, and pressure to publish for career advancement. Suggested actions
against misconduct included removal of published articles, disciplinary warnings, and
restrictions on promotions(4).

In one study, it has been discovered that documented cases represent only the “tip of the
iceberg,” with surveys suggesting that between 0.3–0.8 percent of studies involve serious
misconduct and 5–15% show evidence of QRPs. Retraction rates have also increased sharply,
rising from fewer than 5 per 100,000 publications in 1980 to about 35 per 100,000 in 2011, with
most retractions linked to misconduct rather than error. High-impact journals such as Nature,
Science, and The Lancet show particularly high retraction indices, indicating that misconduct
occurs across the research spectrum, often in the most competitive environments(10).

A study from Nigeria shows that scientific misconduct among Nigerian researchers is
widespread and troubling. Nearly 69% of respondents admitted to engaging in at least one form
of misconduct, with authorship disputes being the most common at 36.4%. More than a quarter
acknowledged falsifying data, while 9.2% admitted to plagiarism, though this figure is likely
underestimated. Authors noted that even when applying the stricter ORI definition, 42% of
researchers still reported misconduct, which is significantly higher than comparable studies in
the US or UK. In plain terms, this means that about seven out of ten researchers surveyed had
engaged in unethical practices, highlighting misconduct as a systemic issue within Nigeria’s
research community(11).

6
A cross-sectional study from Ethiopia showed that Out of 244 respondents, 37.7% admitted to at
least one form of misconduct. The most common was authorship misconduct (47.5%), followed
by fabrication and falsification (40.6%), plagiarism (26.6%), and conflicts of interest (25.4%).
Violations of research ethics regulations, such as conducting studies without proper consent or
ethics approval, were also reported (12). The study added that Key factors associated with
misconduct included publication pressure, which tripled the likelihood of unethical behavior,
academic rank, with junior researchers more likely to engage in misconduct, and school
affiliation, with clinical researchers reporting higher rates of plagiarism and fabrication. Younger
age and less experience were also linked to higher misconduct rates. Ethics training showed
mixed effectiveness, sometimes reducing misconduct but not consistently across all categories
(12).

4.3. Geographic Coverage

The geographic distribution of research misconduct differs from region to region and from
journal to journal. One study showed that Fraud-related retractions were concentrated in
countries with established research traditions such as the United States, Germany, Japan, and
China, while plagiarism and duplication were more common in countries like China and India.
High-impact journals such as Nature, Science, and PNAS were disproportionately affected by
fraud, whereas plagiarism and duplication were more frequent in lower-impact journals(9).

High-profile cases have been reported in countries with long-standing research traditions such as
the United States, Germany, and Japan, where fraud and falsification are more common, while
China and India have shown higher rates of plagiarism and duplicate publication. The
globalization of research means misconduct is no longer confined to specific regions; it is a
worldwide issue, with both developed and developing countries contributing to the rising tide of
retractions(10).

A book on fraud and misconduct in biomedical research showed that Fraud and misconduct in
biomedical research have been reported across both established and emerging research systems,
showing that this is a global issue rather than one confined to a single region. In the United
States, the Office of Research Integrity (ORI) has documented numerous cases of fabrication,

7
falsification, and plagiarism, highlighting the scale of misconduct in a country with a long-
standing research tradition. In Europe, countries such as Germany, France, and the UK have
faced high-profile cases, though their formal oversight systems developed more slowly compared
to the U.S. The Nordic countries (Denmark, Finland, and Norway) established national
committees on scientific dishonesty, offering structured and transparent approaches to handling
misconduct. In Asia, countries like China and India have reported widespread plagiarism and
duplicate publication, often linked to systemic pressures to publish for career advancement. The
pharmaceutical industry in Europe has also encountered fraudulent data in clinical trials,
prompting collective action to safeguard integrity(7).

4.4. Consequences of Research Misconduct

Fraud and misconduct in biomedical research have wide-ranging consequences. At the most
serious level, they can directly harm patients when fabricated or falsified data influences clinical
trials or treatment decisions. This not only endangers lives but can also lead to criminal liability
for those involved. Misconduct distorts the scientific record by introducing unreliable results,
which misleads future research and wastes valuable resources. It undermines public trust in
science and medicine, damaging the credibility of researchers, institutions, and journals. Within
the scientific community, dishonest practices such as ghost authorship, duplicate publication, or
data manipulation unfairly inflate reputations, disadvantaging honest scientists in competition for
grants, promotions, and recognition. Institutions also suffer reputational harm and financial
losses when misconduct is exposed. Overall, the consequences range from patient harm and
wasted resources to loss of trust, career damage, and institutional crises, making misconduct a
serious global challenge(7).

Research misconduct in biomedical science has serious consequences. It can harm patients by
promoting false treatments or giving false hope, as seen in fabricated stem cell research. It
undermines the credibility of science, eroding public trust in research as a reliable and self-
correcting enterprise. Institutions and journals suffer reputational damage when misconduct is
exposed, leading to disgrace for respected academics and editors. Fraudulent studies waste
resources, consuming funding and researcher time that could have supported genuine progress.

8
Misconduct also forces slow and costly reforms, such as the creation of oversight bodies, while
many cases remain hidden or unresolved, leaving the scientific record corrupted(13).

A study by Xinqu Zhang on Research Misconduct in Chinese Universities showed that research
misconduct in Chinese universities has several serious consequences. Faculty members
experience severe emotional and health impacts, including stress, anxiety, depression, and even
physical illness, as a result of intense publication pressures. Career insecurity is common, with
failure to meet strict requirements leading to demotion, salary cuts, or contract termination.
Misconduct becomes normalized, with practices like ghostwriting, fabrication, and plagiarism
rationalized as survival strategies or even seen as emotionally rewarding because they reduce
stress and secure promotions. Institutions suffer damage as aggressive policies erode academic
passion and integrity, turning research into a mechanical quota-driven process and undermining
credibility. In some cases, misconduct is used deliberately for retaliation or resistance, reflecting
anger and resentment. At a systemic level, these patterns risk entrenching misconduct in
academic culture, weakening China’s efforts to build world-class universities and harming its
international reputation(14).

A study in Ethiopia showed that the consequences of scientific misconduct include threats to the
credibility and reliability of scientific research, erosion of trust in institutions, and damage to
Ethiopia’s academic reputation. The authors conclude that misconduct is driven not only by
individual failings but also by systemic pressures and weak institutional oversight. They
recommend stronger policies, mentorship, open dialogue, and targeted support for early-career
researchers to foster a culture of integrity (12).

4.5. Prevention

Mitigating the problem of scientific misconduct is mandatory. A study from Ethiopia reported
that misconduct is driven not only by individual failings but also by systemic pressures and weak
institutional oversight. Authors recommend stronger policies, mentorship, open dialogue, and
targeted support for early-career researchers to foster a culture of integrity (12).

In Fraud and Misconduct in Biomedical Research (Fourth Edition), the prevention of misconduct
is framed as a multi-layered effort that combines institutional oversight, cultural change, and

9
individual responsibility. The book emphasizes promoting good publication practices such as
proper authorship attribution, transparency in reporting, and avoiding duplicate submissions. It
highlights the importance of monitoring research activities through ethics committees that review
protocols and safeguard participants, while also stressing the need for mandatory training in good
scientific practice to instill values of honesty and responsibility in young researchers. Prevention
is further supported by embedding values like truth and justice into the research culture,
publishing anonymized case reports to raise awareness, and establishing independent national or
regional committees to investigate allegations fairly. Together, these mechanisms aim to build a
culture of integrity, reduce opportunities for misconduct, and ensure that biomedical research
remains credible and trustworthy(15).

Prevention strategies such as stronger ethics training, reforms to reduce perverse incentives in
science, greater vigilance by editors and institutions, clearer retraction notices, and centralized
tracking of misconduct cases. Together, these measures aim to strengthen accountability and
protect the integrity of scientific research(9).

In the WHO Code of Conduct for Misconduct in Research, prevention mechanisms are centered
on transparency, accountability, and ethical responsibility. Staff and collaborators are required to
report suspected misconduct either to supervisors or through the confidential Integrity Hotline,
with whistleblowers protected under WHO’s Policy on Whistleblowing and Protection against
Retaliation. Allegations are reviewed through a structured process led by the Ethics team and the
Ethics Review Committee, ensuring independent oversight. The document also stresses the
importance of distinguishing honest errors from deliberate wrongdoing, while encouraging
vigilance against poor practices that could harm public health. These mechanisms, outlined in the
“Report Suspected Wrongdoing” and “Process” sections of the document, aim to prevent
misconduct by fostering a culture of integrity and accountability in research(16).

In Higher Education: Handbook of Theory and Research, Volume XXVIII, the chapter on
Research Integrity and Misconduct in the Academic Profession outlines several prevention
strategies for misconduct. The authors emphasize the importance of ethics education and training
for faculty and students, noting that awareness of responsible conduct of research should be
integrated into graduate programs and professional development. They also recommend

10
institutional oversight mechanisms, such as clear policies, transparent procedures for handling
allegations, and strong leadership commitment to integrity. Another key strategy is creating
supportive research environments—reducing pressures that incentivize misconduct, such as
unrealistic publication demands or inadequate mentoring. Finally, the text highlights the role of
international collaboration standards and the need for consistent guidelines across institutions to
prevent misconduct in cross-border research. These prevention strategies are discussed in the
section beginning on (page 217), where the chapter on research integrity and misconduct is
introduced(1).

5. Conclusion

Research misconduct is a persistent and global challenge that undermines the credibility of
science, erodes public trust, and damages institutions and careers. Its history shows a shift from
isolated scandals handled quietly to structured national and international oversight systems, yet
cases continue to emerge across disciplines and regions. The magnitude of misconduct is
reflected in the rising number of retractions, with fraud, plagiarism, and fabrication dominating,
and surveys revealing troublingly high prevalence among researchers worldwide.
Geographically, misconduct is not confined to any single country or culture—it spans both
established and emerging research systems, driven by systemic pressures such as publication
demands and inadequate oversight. The consequences are severe, ranging from patient harm and
wasted resources to reputational damage and emotional distress for researchers.

Preventing misconduct requires a multi-layered approach: stronger ethics education, transparent

institutional policies, supportive research environments, and international collaboration.
Embedding integrity into the culture of science is essential to safeguard the reliability of research
and ensure that future generations inherit a system built on honesty, accountability, and trust.
Ultimately, the lesson is clear-scientific progress depends not only on innovation but also on the
unwavering commitment to integrity.

11
 6. References

1. National Academies of Sciences, Engineering, and Medicine. Fostering integrity in research

[Internet]. Washington (DC): National Academies Press; 2017 [cited 2026 Jan 8]. Available from:
[Link]

2. Wells F. Historical aspects of research misconduct: Europe. Fraud and Misconduct in Biomedical
Research, 4th edition: CRC Press; 2019. p. 72-85.

3. Gross C. Scientific misconduct. Annual review of psychology. 2016;67(1):693-711.

4. Kokiwar P, Gaiki V, Reddy AS. Prevalence and patterns of research misconduct among medical
college faculties. MRIMS Journal of Health Sciences. 2020;8(2):35-9.

5. Bauchner H, Steinbrook R, Redberg RF. Research Misconduct and Medical Journals. Journal of
Law, Medicine & Ethics. 2025;53(1):35-40.

6. LaFollette MC. The evolution of the “scientific misconduct” issue: an historical overview
(44535C). Proceedings of the Society for Experimental Biology and Medicine. 2000;224(4):211-5.

7. Lock S. Research misconduct 1974-1990: an imperfect history. Fraud and misconduct in

biomedical research. 2001:51.

8. Bhattacharyya S, Chatterjee N, Ramanathan A. Understanding the patterns and magnitude of life

science publication Retractions in the last four decades. International Journal for Educational Integrity.
2025;21(1):17.

12
9. Fang FC, Steen RG, Casadevall A. Misconduct accounts for the majority of retracted scientific
publications. Proceedings of the National Academy of Sciences. 2012;109(42):17028-33.

10. Farthing MJ. Research misconduct: A grand global challenge for the 21st Century. Journal of
gastroenterology and hepatology. 2014;29(3):422-7.

11. Okonta P, Rossouw T. Prevalence of scientific misconduct among a group of researchers in N

igeria. Developing world bioethics. 2013;13(3):149-57.

12. Belay Hailu H, Teka Wolde T, Yirsaw Wubete B, Ali J, Tsegaye Bitew S. Magnitude and Factors
Associated with Research Misconduct at a Public University in Ethiopia: A Cross-Sectional Survey.
F1000Research. 2025;14:111.

13. Smith R. Research misconduct: the poisoning of the well. Journal of the Royal Society of
Medicine. 2006;99(5):232-7.

14. Zhang X. Research Misconduct in Chinese Universities: Towards an Emotional Analysis. Journal
of Academic Ethics. 2025:1-18.

15. Steneck NH. An interpretive history of research misconduct policy in the USA and Canada. Fraud
and Misconduct in Biomedical Research, 4th edition: CRC Press; 2019. p. 55-71.

16. World Health Organization. Code of conduct for misconduct in research [Internet]. Geneva
(Switzerland): WHO; 2017 [cited 2026 Jan 8]. Available from: [Link]
source/documents/ethics/[Link]?
sfvrsn=ac5d50fc_2.

13